Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Recruiting · NCT04363164 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression | Castration Resistant Metastatic Prostate Cancer | Recruiting | Phase 2 | 2026-07-17 | NCT04363164 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 117 |
| United States Department of Defense | 319 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Faber Cancer Institute | Boston | United States | 2 |
| Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | United States | 238 |
| University of California, San Diego (UCSD) | San Diego | United States | 1 |
| University of Minnesota | Minneapolis | United States | 325 |
| University of Nebraska Medical Center | Omaha | United States | 397 |
| University of Washington/Fred Hutchinson Cancer Center | Seattle | United States | 4 |